We are live on ! Find out more
NEPH icon

Nephros
NEPH

18 hedge funds and large institutions have $53.8M invested in Nephros in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more capital invested

Capital invested by funds: $34.8M → $53.8M (+$19M)

0.33% more ownership

Funds ownership: 52.79% → 53.12% (+0.33%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

14% less funds holding

Funds holding: 21 → 18 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
–
Increased
7
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WC
Wexford Capital
Florida
+$556K
2
BA
Bard Associates
Illinois
+$101K
3
Osaic Holdings
Osaic Holdings
Arizona
+$38.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$31.2K
5
CPA
Cowen Prime Advisors
New York
+$30.9K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$123K
2
EP
Elkhorn Partners
Nebraska
-$46K
3
Millennium Management
Millennium Management
New York
-$32.4K
4
SFS
Sowell Financial Services
Arkansas
-$23K
5
SC
Samjo Capital
New York
-$7.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$36.9M +$556K +66,667 +2%
CPA
2
Cowen Prime Advisors
New York
$6.36M +$30.9K +3,700 +0.6%
SC
3
Samjo Capital
New York
$5.63M -$7.51K -900 -0.2%
BA
4
Bard Associates
Illinois
$2.35M +$101K +12,130 +6%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.01M +$31.2K +3,741 +4%
HighTower Advisors
6
HighTower Advisors
Illinois
$565K – – –
William Blair & Company
7
William Blair & Company
Illinois
$368K – – –
BlackRock
8
BlackRock
New York
$238K -$709 -85 -0.4%
Millennium Management
9
Millennium Management
New York
$156K -$32.4K -3,886 -21%
EP
10
Elkhorn Partners
Nebraska
$86K -$46K -5,519 -39%
Morgan Stanley
11
Morgan Stanley
New York
$49K +$8.49K +1,018 +27%
Osaic Holdings
12
Osaic Holdings
Arizona
$46K +$38.1K +4,569 +91,380%
SIC
13
Salem Investment Counselors
North Carolina
$36K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$3K -$8 -1 -0.3%
Wells Fargo
15
Wells Fargo
California
$1K – – –
Bank of America
16
Bank of America
North Carolina
$1K +$292 +35 +140%
Citadel Advisors
17
Citadel Advisors
Florida
– -$123K -18,421 Closed
SFS
18
Sowell Financial Services
Arkansas
– -$23K -2,996 Closed
TCWM
19
Total Clarity Wealth Management
Illinois
– -$4K -653 Closed
UBS Group
20
UBS Group
Switzerland
– -$2.64K -316 -92%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
– -$167 -20 -74%

NEPH Hedge Fund Activity: Q2 2021 in Review

18 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q2 2021, worth a combined $53.8M — up 55% from $34.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NEPH and 0 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Wexford Capital, adding an estimated $556K. The largest seller was Citadel Advisors, exiting entirely with an estimated $123K sold.

  • 18 institutional investors held Nephros (NEPH) as of Q2 2021, down from 21 in Q1 2021.
  • Funds reported $53.8M of Nephros stock for Q2 2021, up 55% quarter-over-quarter.
  • 0 funds opened new Nephros positions in Q2 2021 and 3 closed out, a net change of -3 holders.
  • The largest Nephros buyer in Q2 2021 was Wexford Capital, an estimated $556K added.
  • The largest Nephros seller in Q2 2021 was Citadel Advisors, an estimated $123K sold.

Based on aggregated 13F filings for Q2 2021.